Analysis of 24-hour glycemic excursions in patients with type 1 diabetes by using continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 12, Issue 7, 2010, Pages 523-528

  Taki, Kentaro ^a   Nishimura, Rimei ^a   Morimoto, Aya ^a   Tsujino, Daisuke ^a   Miyashita, Yumi ^a   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; AMBULATORY MONITORING; BLOOD; HYPERGLYCEMIA; JAPAN; METABOLISM; NONPARAMETRIC TEST; PROCEDURES;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; JAPAN; MALE; MONITORING, AMBULATORY; STATISTICS, NONPARAMETRIC;

EID: 77954453975     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0167     Document Type: Article

References (12)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
3. Yu M, Zhou J, Xiang KS, Lu HJ, Ma XJ, Lu W: The glycemic excursions in normal glucose tolerance individuals revealed by continuous glucose monitoring system [in Chinese]. Zhonghua Yi Xue Za Zhi 2004;84:1788-1790.
4. Tsujino D, Nishimura R, Taki K, Miyashita Y, Morimoto A, Tajima N: Daily glucose profiles in Japanese people with normal glucose tolerance as assessed by continuous glucose monitoring. Diabetes Technol Ther 2009;11:457-460.
5. Wang HL, Lu JM, Pan CY, Dou JT, Ba JM: Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system [in Chinese]. Zhonghua Yi Xue Za Zhi 2006;86:674-677.
6. American Association of Clinical Endocrinologists: Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self management-2000 update. Endocr Pract 2000;6:43-84.
7. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; ACCE Diabetes Mellitus Clinical Practice Guidelines Task Force: American Associations of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68. Erratum in: Endocr Pract 2008;14:802-803.
8. IDF Task Force on Clinical Guidelines: Global Guidelines for Type 2 Diabetes. Brussels: International Diabetes Federation, 2006.
9. Chico A, Vidal-Rios P, Subira M, Novials A: The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157.
10. Maia FF, Arauio LR: Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract 2007;75:30-34.
11. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
12. Davidson PC, Hebblewhite HR, Steed RD, Bode BW: Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008;14:1095-1101.